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Abstract In this communication, we demonstrate that D-
aspartate (D-Asp) is synthesized in pheochromocytoma cells
(PC12). To our knowledge this is the first report of biosynthesis
of D-Asp in mammalian cells. Synthesis of D-Asp was demon-
strated by its time-dependent accumulation in the cell culture,
and by the fact that this accumulation was proportional to the
number of inoculated cells. D-Asp in PC12 cells was identified by
(i) co-elution with authentic D-Asp on two different HPLC
columns, an octadesyl silica column and a Pirkle-type chiral
column, (ii) reversed elution order of D-Asp and L-Asp on another
Pirkle-type chiral column with an opposite configuration, and
(iii) sensitivity to D-Asp oxidase. In the cells the amount of D-Asp
was approx. 12^14% of total Asp and no other investigated D-
amino acid was detected. The amount of D-Asp did not increase
during the culture of mouse 3T3 fibroblasts and human
neuroblastoma NB-1 cells. Immunocytochemical staining with
anti-D-Asp antiserum demonstrated that D-Asp synthesized is
present in the cytoplasm of the cells.
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1. Introduction
Recent reports have demonstrated the existence of various
D-amino acids in the mammalian body [1,2]. The transient
appearance of D-aspartate (D-Asp) was demonstrated during
the development of a variety of tissues. Quantitative analysis
by HPLC indicated that the D-Asp level was transiently in-
creased during the development of the cerebral hemisphere of
the rat brain [3,4], and of the retina and the brain of the chick
embryo [5]. In humans, high concentrations of D-Asp (approx.
60% of total Asp is D-form) were found in the prefrontal
cortex at gestational week 14, but this level rapidly decreased
to a trace level at delivery [6]. Immunohistochemical study
with anti-D-Asp antiserum prepared previously in this labora-
tory demonstrated that D-Asp was localized in speci¢c types
of cells in various endocrine tissues such as testis [7], adrenal
[8], pineal [9] and pituitary glands [10] (Lee et al., unpublished
observation) at distinct periods of development. The periods
of maximal appearance of D-Asp corresponded well with
those of the morphological and functional maturation in the
respective tissues [4,7,11]. Concerning its physiological func-
tion(s), D-Asp is reported to have an a⁄nity for the glutamate
(Glu) binding site of the N-methyl-D-aspartate (NMDA) re-
ceptor [12^15] and to be involved in testosterone synthesis in
rat testis [16]. These lines of evidence suggest that D-Asp is
related to the regulation of the maturation and di¡erentiation
of the cells in the brain and endocrine tissues, although the
details remain to be clari¢ed.
It is clear that D-amino acids found in bacteria [17], plants
[18] and the lower animals such as insects [19], prawns [20,21],
cray¢sh [20] and bivalves [22] are synthesized by racemases or
D-amino acid transaminases. However, it is not known
whether D-Ser and D-Asp are synthesized in mammals, since
these D-amino acids in diet can be absorbed by the intestine
and transported to various tissues in mammals [1,2,23]. Neidle
and Dunlop [5] observed that the amounts of D-Asp increased
signi¢cantly in fertilized chicken eggs during incubation. Since
the egg is a closed system without dietary supplementation,
this result indicates biosynthesis of D-Asp in chicken embryos
and the biosynthesis could also reasonably occur in the mam-
malian body. However, direct evidence of biosynthesis of D-
Asp has not yet been established in mammals. Because of the
predominant presence of D-Asp in medullar cells of the rat
adrenal gland [4,8,10] and the transient appearance of D-Asp
during ontogeny of the rat brain [3,4], we investigated the
biosynthesis of D-Asp in a cell line of PC12 cells. These cells
are derived from the rat adrenal medulla and can be di¡er-
entiated into neuronal cells upon stimulation with various
growth factors (e.g. nerve growth factor (NGF)). Hence,
they possess the features of both adrenal medullar cells and
of neurons. To our knowledge this is the ¢rst report demon-
strating biosynthesis of D-Asp in mammalian cells. The
present observation should contribute to our understanding
of the D-Asp synthetic pathway and the physiological func-
tions of D-Asp in mammalian cells.
2. Materials and methods
2.1. Materials
Mycoplasma-free PC12 cells were obtained from Rikken Cell Bank
(Tsukuba, Japan) and NB-1 cells were from Health Science Research
Resources Bank (Tokyo, Japan). Swiss 3T3 cells were kindly donated
by Prof. T. Katada (Univ. Tokyo). A puri¢ed preparation of D-Asp
oxidase from Cryptococcus humicolus UJ1 was obtained as described
previously [24]. NGF (2.5S), trypsin, penicillin and streptomycin were
obtained from Sigma (St. Louis, MO, USA). 4-Fluoro-7-nitro-2,1,3-
benzoxadiazole (NBD-F) was from Wako (Osaka, Japan). The re-
verse-phase column (ODS-M80 250U4.6 mm) and Pirkle-type chiral
columns, Sumichiral OA2500S and OA2500R, were kindly supplied
by Tosoh (Tokyo, Japan) and Sumika Chemical Analysis Service
(Osaka, Japan), respectively. [4-14C]-D-Asp was purchased from
American Radiolabeled Chemicals (St. Louis, MO, USA). Sera used
in cell culture were checked to make sure that they were free of
mycoplasma.
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2.2. Cell culture
PC12 cells were cultured on collagen (type I)-coated polystyrene
plates (Iwaki Glass, Tokyo, Japan) at 37‡C under 5% CO2 and
100% humidity. Cultured cells were passaged with 0.1% trypsin in
Hanks’ balanced salt solution (Gibco-BRL, New York, NY, USA).
Growth culture medium consisted of Dulbecco’s modi¢ed Eagle me-
dium (DMEM) (Gibco-BRL) containing 5% of heat-inactivated fetal
bovine serum (FBS) (Gibco-BRL) and 5% heat-inactivated horse se-
rum (Gibco-BRL). Di¡erential culture medium, TIP/DF, is composed
of a mixture of DMEM and F12 (Gibco-BRL) (1:1) containing 1%
N1 medium supplement (Sigma) and 50 ng/ml of NGF. All the media
additionally contained 100 units/ml of streptomycin and 100 units/ml
of penicillin.
Swiss 3T3 cells were cultured in DMEM containing 5% FBS and
NB-1 cells in the mixture of RPMI-1640 (Gibco-BRL) and minimum
essential medium (Gibco-BRL) (1:1) containing 10% FBS. Both cells
were inoculated on 6-well polystyrene plates and the other conditions
were the same as those of PC12 cells.
2.3. Sample preparation
Amino acids in the culture media were extracted with four volumes
of methanol. One ml of methanol was added to the cells on the plate,
followed by 10 min sonication in order to extract cellular amino acids.
These methanol extracts were centrifuged at 5000Ug for 10 min, and
supernatants were evaporated to dryness, followed by £uorescent de-
rivatization with NBD-F according to the method described in our
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Fig. 1. Enantiomeric separation and identi¢cation of D-Asp in PC12 cells. The Asp fraction in cultured PC12 cells was isolated by reverse-phase
HPLC as described in Section 2 and enantiomeric separation of the fractions was carried out by HPLC on a Pirkle-type chiral column (Sumi-
chiral OA2500S). The cells (1.0U106 cells) were cultured in DMEM for 5 days (a) and in TIP/DF medium for 7 days (b). c: A fraction of b
was subjected to HPLC on a OA2500R column. d: An amino acid preparation of b was pretreated with D-Asp oxidase before isolation and
enantiomeric separation. Thirty-seven mU of D-Asp oxidase in 0.2 ml of phosphate bu¡er was used for the residue of 0.2 ml methanol extracts
of the cells.
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previous report [11]. Quanti¢cation of the amino acids was carried out
by HPLC as described below.
In the experiment to investigate the e¡ect of exogenous D-Asp on
cellular D-Asp levels, PC12 cells were cultured in the presence of
[4-14C]-D-Asp. After removing the medium, cells were then washed
two times with 1 ml of cold Hanks’ balanced salt solution, and amino
acids were extracted as described above. Portions of the extracts were
used both for liquid scintillation counting and for D-Asp determina-
tion.
Enantioselective enzymatic oxidation of D-Asp was done in 100
mM sodium phosphate bu¡er, pH 7.5, containing 0.1% bovine serum
albumin and 50 WM FAD. After the reaction, amino acids were ex-
tracted and derivatized as described above and the samples were sub-
jected to HPLC analysis.
2.4. HPLC analysis
The determination of D,L-amino acid contents was carried out by a
combination of reverse-phase HPLC and HPLC with a Pirkle-type
chiral column as described in our previous report [11]. Brie£y, the
isolation and quanti¢cation of individual amino acids were performed
by reverse-phase HPLC with £uorometric detection. Subsequently,
enantiomeric separation of individual amino acids was carried out
by HPLC with Sumichiral 2500S. A chiral column of an opposite
chiral center (Sumichiral OA2500R) was also used for the identi¢ca-
tion of D-Asp.
2.5. Immunocytochemical staining
PC12 cells were mounted on collagen-coated glass slides. After cul-
tivation for 2 days, cells were ¢xed with Karnovsky solution (2.5%
glutaraldehyde, 2% paraformaldehyde and 0.1 M sodium cacodylate,
pH 7.2) for over 30 min at 4‡C. The ¢xed cells were treated with 0.5%
NaBH4 in PBS for 20 min, blocked with 3% BSA and 0.1% Tween 20
for 30 min and incubated overnight with anti-D-Asp antibody at room
temperature. The stereospeci¢c anti-D-Asp antibody was previously
prepared in this laboratory [7,9]. The immunoreactivity (IR) was vi-
sualized by the peroxidase-antiperoxidase method using the PAP com-
plex (Dako Japan, Tokyo, Japan). The slides were observed under a
light microscope after the diamino-benzidine-H2O2 reaction and
counterstaining with hematoxylin.
2.6. Statistic analysis
Results were expressed as mean þ standard deviation. Signi¢cant
di¡erences between groups were determined by Duncan’s multiple-
range test.
3. Results
3.1. D-Asp synthesis in PC12 cells
The Asp fractions isolated from PC12 cells cultured either
in growth medium (Fig. 1a) or in di¡erentiation medium (Fig.
1b) were subjected to enantiomeric separation on a chiral
column. D-Asp contents were 14.3% and 12.4% of total Asp
(D+L), respectively. The same fraction was also separated on
another chiral column of an opposite con¢guration. The elu-
tion order of D,L-Asp was reversed, as shown in Fig. 1c, con-
¢rming that the peak was that of D-Asp, and not that of other
possible contaminants. In addition, this peak was found to be
sensitive to D-Asp oxidase treatment, an oxidative deamina-
tion enzyme with high stereospeci¢city for D-Asp but not for
L-Asp. Fig. 1d shows that the D-Asp peak was considerably
diminished to a very low level after the treatment with this
enzyme, further con¢rming that it was that of D-Asp. No
other D-amino acids such as D-alanine, -Ser, -Glu, -threonine
and -proline were found in signi¢cant quantities (data not
shown).
The time course of D-Asp increase was examined in the cells
and the media during culture (Fig. 2). The level of D-Asp
increased with the culture time, irrespective of the type of
culture medium used. On the contrary, the D-Asp levels in
the cultures of mouse ¢broblast Swiss 3T3 cells and in human
neuroblastoma NB-1 cells remained practically unchanged (D-
Asp levels in 3T3 cells were 40.2 þ 6.3 (1 day), 33.8 þ 1.1
(2 days) and 28.7 þ 1.8 pmol/dish (3 days), respectively, and
those in the media were 296 þ 3.5 (1 day), 253 þ 0.4 (2 days)
and 251 þ 26.4 pmol/dish (3 days), respectively; data of NB-1
cells not shown).
In Fig. 3, the net increase in D-Asp in cells and media was
evaluated three days after inoculation of the cultures with
various numbers of PC12 cells. The amount of D-Asp in
both the cells and media increased signi¢cantly during culture
in TIP/DF medium, regardless of the presence of NGF. A
three day incubation of cell-free medium that had previously
served to cultivate PC12 cells did not result in any change in
the amount of D-Asp. These lines of evidence indicate that D-
Asp is synthesized in the culture of PC12 cells, since this
amino acid is not supplemented during the culture.
It was possible that D-Asp is synthesized outside PC12 cells
(e.g. by contaminating microorganisms) and then taken up
into the cells. However, the results shown in Fig. 4 excluded
this possibility. We cultivated PC12 cells in the presence of
various amounts of radiolabeled D-Asp in order to investigate
the e¡ects of exogenous D-Asp on its intracellular level. Exog-
enous D-Asp up to the concentration of 1 WM did not a¡ect
the intracellular D-Asp level (Fig. 4). After the culture, only
about 1.3^6 pmol of exogenous D-Asp was recovered from the
cells, whereas an increase of more than 150 pmol of D-Asp
was observed in the cells (Fig. 4). These results further indi-
cate that biosynthesis of D-Asp takes place in PC12 cells, not
outside the cells.
3.2. Localization of D-Asp in the cytoplasm of PC12 cells
The localization of D-Asp in PC12 cells was investigated by
an immunocytochemical method using anti-D-Asp antiserum
prepared previously in this laboratory [7^9]. Fig. 5 demon-
strates that D-Asp immunoreactivity (IR) is mainly observed
in the cytoplasm of PC12 cells. Although IR was apparent
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Fig. 2. Time-dependent D-Asp accumulations in the cultures of
PC12. PC12 cells (7U105 for DMEM, 5U105 for TIP/DF) were in-
oculated on (6-well) collagen-coated polystyrene plates and were
precultured for 1 day. Cellular contents at this stage were taken as
the controls and arbitrarily de¢ned as those of 0 day. After culture
for 2 and 4 days, D-Asp contents in the cells and the media were
determined. Bar: S.D. for experiments in triplicate. **: Signi¢cantly
di¡erent compared to control (0 day), P6 0.01, n = 3. L-Asp levels
in the cells cultured in DMEM were 6.01 þ 0.66 (0 day), 10.00 þ 0.86
(2 days) and 3.33 þ 0.65 nmol/dish (4 days), respectively, and D%
(D-Asp/total Asp) in the cells were 1.95 (0 day), 3.10 (2 days) and
13.6% (4 days), respectively.
Z. Long et al./FEBS Letters 434 (1998) 231^235 233
over the entire cytoplasm, the intensity between the cells was
somewhat di¡erent (Fig. 5). Preabsorption of antiserum with
D-Asp hapten abolished IR and preimmune serum revealed no
IR (data not shown).
4. Discussion
In this study, we have provided the ¢rst indication that D-
Asp is actually synthesized in mammalian cells. The amount
of D-Asp increased with the culture time of PC12 cells, and
this increase was proportional to the size of the cell inoculum.
D-Asp in PC12 cells was identi¢ed according to the following
criteria: (i) co-migration with authentic D-Asp on two di¡er-
ent HPLC columns, an octadesyl silica column and a subse-
quent Pirkle-type chiral column; (ii) reversed elution order of
the D and L forms of Asp from a chiral HPLC column with an
opposite chiral center; (iii) sensitivity to treatment with enan-
tioselective D-Asp oxidase; (iv) in addition, positive immuno-
cytochemical staining using an anti-D-Asp antiserum. Radio-
labeled D-Asp in the medium was not incorporated into PC12
cells (Fig. 4). This is consistent with the previous reports that
glutamate/aspartate transporter activity is not present in PC12
cells [25,26], since this transporter has an a⁄nity for D-Asp in
addition to L-Glu and L-Asp [27,28]. Fig. 4 demonstrates that
a signi¢cant amount of D-Asp increased in the cells, whereas
exogenous D-Asp was not taken up into PC12 cells. This result
indicates that biosynthesis of D-Asp takes place in PC12 cells,
not outside the cells.
The result showing that D-Asp was not increased in mouse
3T3 ¢broblasts or in human neuroblastoma NB-1 cells implies
that D-Asp synthesis is not ubiquitous but speci¢c to PC12
cells. Our recent investigation indicates that D-Asp is not syn-
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Fig. 3. Cell number-dependent D-Asp increase in PC12 cell cultures. Various numbers of PC12 cells were cultured for 3 days in TIP/DF me-
dium in the presence (a) and absence (b) of NGF (50 ng/mg). The net increase of D-Asp contents in the cells and cells plus medium (total) dur-
ing 3 days were presented. Bar: S.D. for experiments in triplicate. *: Signi¢cantly di¡erent compared to control, P6 0.05, n = 3; **: P6 0.01,
n = 3.
Fig. 4. Exogenous D-Asp is not taken up into the cells and has no
e¡ect on the cellular levels of D-Asp in PC12 cell cultures. PC12
cells (1U106 cells) were precultured in DMEM for 1 day. Cellular
contents at this stage were taken as control and arbitrarily de¢ned
as those of 0 day. Culture was continued for 2 days after the media
had been changed to TIP/DF containing various concentrations of
radiolabeled D-Asp (0, 0.25, 0.5, 1.0 WM). The fresh medium con-
tained approx. 25 nM D-Asp. D-Asp contents and radioactivities in
cells were determined by HPLC and liquid scintillation counting as
described in Section 2. After the culture, only approx. 1.3^6 pmol
of the exogenous D-Asp (corresponding to about 0.3% of the radio-
activity added) was recovered from the cells. Bar: S.D. for experi-
ments in triplicate. **: Signi¢cantly di¡erent compared to control
(0 day), P6 0.01, n = 3.
Fig. 5. Immunocytochemical staining of PC12 cells with anti-D-Asp
antibody. PC12 cells cultured in DMEM for 3 days were probed
with anti-D-Asp antiserum by the method described in the text. The
arrows indicate two cells with di¡erent intensities. Bar: 25 Wm.
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thesized in the primary culture of rat pinealocytes, parenchy-
mal cells of the pineal gland which contain signi¢cant
amounts of D-Asp (Takigawa, Y. et al., unpublished observa-
tion). Since no other investigated D-amino acid was detected,
PC12 cells would appear to produce D-Asp selectively. On the
other hand, the present data also shows that D-Asp synthesis
in PC12 cells is not a¡ected by NGF, indicating that D-Asp is
not a consequence of cell di¡erentiation.
Immunostaining reveals that D-Asp is localized in the cyto-
plasm, consistent with the observations in the rat pineal [9,10],
adrenal [8,10], testis [7] and brain [10]. The staining intensity
of D-Asp is di¡erent between the cells as shown in Fig. 5,
although details of the regulation of the cellular D-Asp level
will require further investigation.
As described above, it has been reported that cloned sub-
types of L-Glu transporters have a⁄nities for D-Asp in addi-
tion to L-Glu and L-Asp [27,28]. Indeed, D-Asp administered
intraperitoneally [16] or intravenously [29] is incorporated into
a variety of organs such as testis, pituitary, adrenal and pineal
glands, possibly via the transporters on the plasma mem-
branes of the cells. The present data (Figs. 2 and 3) have
revealed that signi¢cant amounts of the D-Asp produced in
PC12 cells are released into the medium, although the details
on the release mechanism remain to be investigated. We there-
fore presume that D-Asp is produced in certain tissue(s) of the
mammalian body and transferred to other tissues via the vas-
cular system.
As regards the synthetic pathway(s) of D-amino acids, they
can be produced by racemases or D-amino acid aminotrans-
ferase (see Section 1). Recent reports [30^33] suggest that D-
Ser is synthesized in the mammalian body. However, since
most of these reports concern in vivo studies the exact syn-
thetic pathway(s) of D-Ser require further clari¢cation.
As for the synthetic pathway(s) of D-Asp in mammals, little
information is available. Aspartate racemase genes have been
cloned both from the archaebacterium Desulfurococcus strain
SY [34], and from the eubacterium Streptococcus thermophilus
[35]. Despite the evolutionary distance that separates them,
both display good homology, implying that D-Asp racemase
might be a common enzyme in living organisms. In this study,
we demonstrated the biosynthesis of D-Asp in a mammalian
cell line which should provide a useful model for the elucida-
tion of the synthetic pathway and for genetic analysis.
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